A detailed history of Barclays PLC transactions in Utah Medical Products Inc stock. As of the latest transaction made, Barclays PLC holds 4,574 shares of UTMD stock, worth $280,980. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,574
Previous 4,574 -0.0%
Holding current value
$280,980
Previous $306,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$65.79 - $75.08 $205,133 - $234,099
3,118 Added 214.15%
4,574 $306,000
Q2 2024

Aug 14, 2024

SELL
$65.92 - $70.99 $73,962 - $79,650
-1,122 Reduced 43.52%
1,456 $97,000
Q1 2024

May 15, 2024

SELL
$68.14 - $84.23 $148,477 - $183,537
-2,179 Reduced 45.81%
2,578 $184,000
Q4 2023

Feb 15, 2024

BUY
$77.07 - $87.05 $316,141 - $357,079
4,102 Added 626.26%
4,757 $401,000
Q3 2023

Nov 07, 2023

SELL
$83.86 - $99.16 $2,515 - $2,974
-30 Reduced 4.38%
655 $57,000
Q2 2023

Aug 03, 2023

SELL
$87.76 - $99.95 $93,464 - $106,446
-1,065 Reduced 60.86%
685 $64,000
Q1 2023

May 04, 2023

BUY
$87.14 - $100.3 $71,890 - $82,747
825 Added 89.19%
1,750 $166,000
Q4 2022

Feb 13, 2023

BUY
$82.45 - $101.88 $64,228 - $79,364
779 Added 533.56%
925 $93,000
Q3 2022

Nov 03, 2022

SELL
$80.73 - $95.26 $2,179 - $2,572
-27 Reduced 15.61%
146 $12,000
Q2 2022

Aug 12, 2022

SELL
$81.49 - $90.28 $31,373 - $34,757
-385 Reduced 69.0%
173 $15,000
Q1 2022

May 16, 2022

SELL
$86.04 - $99.89 $309,657 - $359,504
-3,599 Reduced 86.58%
558 $50,000
Q4 2021

Feb 14, 2022

BUY
$88.84 - $124.71 $244,665 - $343,451
2,754 Added 196.29%
4,157 $415,000
Q3 2021

Nov 09, 2021

BUY
$84.89 - $97.16 $82,088 - $93,953
967 Added 221.79%
1,403 $130,000
Q2 2021

Aug 13, 2021

SELL
$82.4 - $89.39 $199,160 - $216,055
-2,417 Reduced 84.72%
436 $37,000
Q1 2021

May 13, 2021

BUY
$83.74 - $92.99 $146,712 - $162,918
1,752 Added 159.13%
2,853 $248,000
Q4 2020

Feb 11, 2021

SELL
$79.35 - $94.4 $36,739 - $43,707
-463 Reduced 29.6%
1,101 $93,000
Q3 2020

Nov 12, 2020

SELL
$78.22 - $92.62 $25,265 - $29,916
-323 Reduced 17.12%
1,564 $126,000
Q2 2020

Aug 12, 2020

BUY
$78.0 - $106.28 $147,186 - $200,550
1,887 New
1,887 $167,000
Q1 2020

May 13, 2020

SELL
$77.05 - $108.52 $322,762 - $454,590
-4,189 Closed
0 $0
Q4 2019

Feb 10, 2020

BUY
$91.85 - $109.3 $162,207 - $193,023
1,766 Added 72.88%
4,189 $453,000
Q3 2019

Nov 14, 2019

SELL
$83.55 - $100.0 $127,330 - $152,400
-1,524 Reduced 38.61%
2,423 $232,000
Q2 2019

Aug 14, 2019

BUY
$77.76 - $95.7 $229,936 - $282,984
2,957 Added 298.69%
3,947 $378,000
Q1 2019

May 15, 2019

BUY
$80.49 - $99.2 $71,636 - $88,288
890 Added 890.0%
990 $88,000
Q4 2018

Feb 14, 2019

SELL
$74.64 - $97.62 $136,143 - $178,058
-1,824 Reduced 94.8%
100 $8,000
Q3 2018

Nov 14, 2018

BUY
$86.0 - $114.75 $3,784 - $5,049
44 Added 2.34%
1,924 $181,000
Q2 2018

Aug 14, 2018

SELL
$95.3 - $116.0 $31,258 - $38,048
-328 Reduced 14.86%
1,880 $207,000
Q1 2018

May 15, 2018

BUY
$79.3 - $99.1 $84,533 - $105,640
1,066 Added 93.35%
2,208 $218,000
Q4 2017

Feb 14, 2018

BUY
$74.4 - $84.05 $34,447 - $38,915
463 Added 68.19%
1,142 $93,000
Q3 2017

Nov 14, 2017

BUY
$68.55 - $74.65 $46,545 - $50,687
679
679 $50,000

Others Institutions Holding UTMD

About UTAH MEDICAL PRODUCTS INC


  • Ticker UTMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 3,625,200
  • Market Cap $223M
  • Description
  • Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO u...
More about UTMD
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.